×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lung Cancer

Angelica Welch
An immunotherapy pair looks promising for those with pleural mesothelioma, which is now treated with chemotherapy.
Kristie L. Kahl
According to findings from the ASCO Annual Meeting, insurance disparities still exist, and may even contribute to cancer-specific and comorbidity-associated mortalities in patients with early-stage non-small cell lung cancer.
Andrew Smith
A new expert guideline for managing immunotherapy’s side effects has been released.
Sandra Shaw
Lung cancer registries, like the Bonnie J. Addario Lung Cancer Foundation's, can be beneficial to patients and researchers.
Kristie L. Kahl
Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Kristie L. Kahl
In the Keynote-042 trial, researchers found a four- to eight-month overall survival benefit among patients with non-small cell lung cancer (NSCLC), which was correlated with higher levels of PD-L1 expression, however, further study is warranted.
H. Jack West, M.D.
Some immunotherapy drugs target the PD-L1 protein, though this expert says that it is still an imperfect biomarker.
Kristie L. Kahl
Racial disparities in palliative and hospice care beliefs appear to influence early integration in to standard oncologic care for patients with advanced lung cancer.
Kristie L. Kahl
An expert from Texas Oncology offers perspective on findings from the CCGA study – presented at the 2018 ASCO Annual Meeting – which may support the use of a blood test to detect lung cancer earlier.
Kristie L. Kahl
In this week’s episode of CURE Talks Cancer, we spoke with lung cancer survivor Taylor Bell Duck about her cancer journey and celebrating survivorship 10 years later.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable